Clinical Trial Update: An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More [Phase 4]

View source ↗

Summary

An open-label, non-randomized Phase 4 pilot study evaluated preservative-free tafluprost (Saflutan) in patients with ocular hypertension or primary open-angle g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Saflutan (tafluprost)

Snippet

Sponsor: Dr. Anton Hommer | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED